Glutamate receptor abnormalities in the YAC128 transgenic mouse model of Huntington’s disease
- 29 June 2007
- journal article
- Published by Elsevier in Neuroscience
- Vol. 147 (2) , 354-372
- https://doi.org/10.1016/j.neuroscience.2007.03.010
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse modelsNeurobiology of Disease, 2006
- Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's diseaseMolecular and Cellular Neuroscience, 2004
- AMPA RECEPTOR REGULATION MECHANISMS: FUTURE TARGET FOR SAFER NEUROPROTECTIVE DRUGSInternational Journal of Neuroscience, 2004
- Expression of Polyglutamine-expanded Huntingtin Induces Tyrosine Phosphorylation of N-Methyl-D-aspartate ReceptorsJournal of Biological Chemistry, 2003
- Published by Elsevier ,2001
- Regional and Ontogenic Expression of the NMDA Receptor Subunit NR2D Protein in Rat Brain Using a Subunit‐Specific AntibodyJournal of Neurochemistry, 1996
- Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic MiceCell, 1996
- Proton magnetic resonance spectroscopy in Huntington's disease: Evidence in favour of the glutamate excitotoxic theory?Movement Disorders, 1996
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomesCell, 1993
- A Family of AMPA-Selective Glutamate ReceptorsScience, 1990